Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on the Section 232 Pharmaceutical…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to…
Learn more
BIO Statement on Passage of Legislation…
WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…
Learn more
Announcing Investor Connect Plus: A LaunchBio x…
Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
Will Smith to Deliver Keynote at 2016 BIO International Convention
May 13, 2016
Actor, producer, musician and philanthropist recently playedDr. Bennet Omalu in the film, “Concussion”
BIO’s Livestock Biotech Summit Becomes Animal Biotech Summit to Reflect New Theme and Goals
May 12, 2016
“Advancing One Health through Biotechnology”
BIO Applauds Senators Heitkamp, Heller and Peters for Introducing the SEC Small Business Advocate Act
April 29, 2016
Bill would enhance the voice of emerging companies at the SEC
BIO Collaborates with NIH and NSF on Growing “Innovation Zone” at BIO 2016 International Convention
April 29, 2016
The Biotechnology Innovation Organization (BIO), the National Science Foundation (NSF) and the National Institutes of Health (NIH) today announced an agreement to feature Small Business Innovation Research (SBIR)-funded early-stage biomedical…
BIO Statement on USTR’s 2016 “Special 301 Report”
April 28, 2016
The Biotechnology Innovation Organization (BIO) released the following statement regarding The Office of the United States Trade Representative’s (USTR) 2016 Special 301 Report:
The 2016 BIO World Congress on Industrial Biotechnology Closed with a Record Number of Partnering Meetings
April 25, 2016
This year’s Conference drew around 907 industry leaders from 529 companies, 32 countries and 31 states, as well as the District of Columbia. Organized by the Biotechnology Innovation Organization (BIO), the World Congress on Industrial…
CSRxP Plan Fails to Tackle Real Drivers of Consumer Out of Pocket Costs
April 25, 2016
The Biotechnology Innovation Organization (BIO) issued the following statement today regarding the Campaign for Sustainable Rx Pricing’s policy proposals on prescription drug prices:
BIO Presents Dr. Ganesh Kishore New Award for Leadership and Legacy in Industrial Biotechnology
April 20, 2016
BIO presented Dr. Ganesh Kishore, CEO, MLSCFI and co-Managing Partner, Spruce Capital Partners, the first annual BIO Leadership and Legacy Award today during BIO’s 13th Annual World Congress on Industrial Biotechnology. The new…
Kentucky Governor Bevin Signs Bill Ensuring Patient Access to Interchangeable Biologic Medicines
April 15, 2016
The Biotechnology Innovation Organization (BIO) and Kentucky Life Science Council (KLSC) commend Governor Matt Bevin for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines.
Media Advisory: NexSteppe CEO Anna Rath to Receive BIO Award Honoring an Outstanding Woman in Industrial Biotechnology
April 14, 2016
President and CEO of NexSteppe Anna Rath will deliver remarks and will be presented the Rosalind Franklin Award by the Biotechnology Innovation Organization (BIO) at the 2016 World Congress on Industrial Biotechnology in San Diego on Tuesday April…